Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Lymphoma • Internal Medicine • Hematology • Dermatology
How long do you give systemic therapies or skin directed therapies to work before changing treatments in patients with diffuse skin limited mycoses fungoides?
Do you have a preferred sequence of therapies for diffuse skin limited MF?
Answer from: Medical Oncologist at Community Practice
It really depends on the patient, the side effects profile. Some systemic therapies are “skin directed” like bexarotene. Also, access to a dermatologist's office for nbUVB is an important factor in making such a decision. I generally don’t recommend topical agents when there is mor...
Sign in or Register to read more